The expression and distribution of group IIA phospholipase A2 in human colorectal tumours

Virchows Archiv

Volumn 457, Issue 6, 2010, Pages 659-667

  Avoranta, Tuulia ^a   Sundström, Jari ^a   Korkeila, Eija ^a   Syrjänen, Kari ^a   Pyrhönen, Seppo ^a   Laine, Jukka ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Colorectal adenoma; Colorectal carcinoma; Group IIA phospholipase A2; Localisation

Indexed keywords

PHOSPHOLIPASE A2 GROUP II;

ADULT; AGED; APOPTOSIS; ARTICLE; BENIGN TUMOR; CANCER GRADING; CANCER STAGING; CELL DEATH; COLON POLYP; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISEASE SEVERITY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; PRECANCER; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECTUM POLYP; TUMOR CELL; TUMOR LOCALIZATION;

ADENOMA; AGED; AGED, 80 AND OVER; APOPTOSIS; BIOPSY; CARCINOMA; COLORECTAL NEOPLASMS; EPITHELIAL CELLS; FEMALE; GROUP II PHOSPHOLIPASES A2; HUMANS; MALE; MIDDLE AGED; NECROSIS; RETROSPECTIVE STUDIES; RNA, MESSENGER;

EID: 78651323054     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-010-0992-7     Document Type: Article

References (45)

1. Laye JP, Gill JH (2003) Phospholipase A2 expression in tumours: a target for therapeutic intervention? Drug Discov Today 8:710-716
2. Tanaka T (2009) Colorectal carcinogenesis: review of human and experimental animal studies. J Carcinogen 8:5
3. Greenhough A, Smartt HJ, Moore AE, Roberts HR, Williams AC, Paraskeva C, Kaidi A (2009) The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis 30:377-386
4. Yuan CJ, Mandal AK, Zhang Z, Mukherjee AB (2000) Transcriptional regulation of cyclooxygenase-2 gene expression: novel effects of nonsteroidal anti-inflammatory drugs. Cancer Res 60:1084-1091
5. Wendum D, Comperat E, Boëlle PY, Parc R, Masliah J, Trugnan G, Fléjou JF (2005) Cytoplasmic phospholipase A2 alpha overexpression in stromal cells is correlated with angiogenesis in human colorectal cancer. Mod Pathol 18:212-220
6. Panel V, Boëlle PY, Ayala-Sanmartin J, Jouniaux AM, Hamelin R, Masliah J, Trugnan G, Fléjou JF, Wendum D (2006) Cytoplasmic phospholipase A2 expression in human colon adenocarcinoma is correlated with cyclooxygenase-2 expression and contributes to prostaglandin E2 production. Cancer Lett 243:255-263
7. Nevalainen TJ, Haapanen TJ (1993) Distribution of pancreatic (group I) and synovial-type (group II) phospholipases A2 in human tissues. Inflammation 17:453-464
8. Nevalainen TJ, Kortesuo PT, Rintala E, Märki F (1992) Immunochemical detection of group I and group II phospholipases A2 in human serum. Clin Chem 38:1824-1829
9. Rintala EM, Nevalainen TJ (1993) Group II phospholipase A2 in sera of febrile patients with microbiologically or clinically documented infections. Clin Infect Dis 17:864-870
10. Graff JR, Konicek BW, Deddens JA, Chedid M, Hurst BM, Colligan B, Neubauer BL, Carter HW, Carter JH (2001) Expression of group IIa secretory phospholipase A2 increases with prostate tumor grade. Clin Cancer Res 7:3857-3861 (Pubitemid 34044601)
11. Jiang J, Neubauer BL, Graff JR, Chedid M, Thomas JE, Roehm NW, Zhang S, Eckert GJ, Koch MO, Eble JN, Cheng L (2002) Expression of group IIA secretory phospholipase A2 is elevated in prostatic intraepithelial neoplasia and adenocarcinoma. Am J Pathol 160:667-671 (Pubitemid 34160344)
12. Mirtti T, Laine VJ, Hiekkanen H, Hurme S, Rowe O, Nevalainen TJ, Kallajoki M, Alanen K (2009) Group IIA phospholipase A as a prognostic marker in prostate cancer: relevance to clinicopathological variables and disease-specific mortality. APMIS 117:151-161
13. Leung SY, Chen X, Chu KM, Yuen ST, Mathy J, Ji J, Chan AS, Li R, Law S, Troyanskaya OG, Tu IP, Wong J, So S, Bostein D, Brown PO (2002) Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis. Proc Natl Acad Sci USA 99:16203-16208
14. Wendum D, Svreck M, Rigau V, Boëlle PY, Sebbagh N, Parc R, Masliah J, Trugnan G, Fléjou JF (2003) COX-2, inflammatory secreted PLA2, and cytoplasmic PLA2 protein expression in small bowel adenocarcinomas compared with colorectal adenocarcinomas. Mod Pathol 16:130-136
15. Buhmeida A, Bendardaf R, Hilska M, Laine J, Collan Y, Laato M, Syrjänen K, Pyrhönen S (2009) PLA2 (group IIA phospholipase A2) as a prognostic determinant in stage II colorectal carcinoma. Ann Oncol 20:1230-1235
16. Nevalainen TJ, Grönroos JM, Kallajoki M (1995) Expression of group II phospholipase A2 in the human gastrointestinal tract. Lab Invest 72:201-208
17. Hong KH, Bonventre JC, O'Leary E, Bonventre JV, Lander ES (2001) Deletion of cytosolic phospholipase A(2) suppresses Apc (Min)-induced tumorigenesis. Proc Natl Acad Sci USA 98:3935-3939
18. Edhemovic I, Snoj M, Kljun A, Golouh R (2001) Immunohistochemical localization of group II phospholipase A2 in the tumours and mucosa of the colon and rectum. Eur J Surg Oncol 27:545-548
19. Kennedy BP, Soravia C, Moffat J, Xia L, Hiruki T, Collins S (1998) Overexpression of the non-pancreatic secretory group II PLA2 messenger RNA and protein in colorectal adenomas from familial adenomatous polyposis patients. Cancer Res 58:500-503
20. Haapamäki MM, Grönroos JM, Nurmi H, Alanen K, Kallajoki M, Nevalainen TJ (1997) Gene expression of group II phospholipase A2 in intestine in ulcerative colitis. Gut 40:95-101
21. Haapamäki MM, Grönroos JM, Nurmi H, Alanen K, Nevalainen TJ (1999) Gene expression of group II phospholipase A2 in intestine in Crohn's disease. Am J Gastroenterol 94:713-720
22. Minami T, Tojo H, Shinomura Y, Matsuzawa Y, Okamoto M (1994) Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis. Gut 35:1593-1598
23. Minami T, Shinomura Y, Miyagawa J, Tojo H, Okamoto M, Matsuzawa Y (1997) Immunohistochemical localization of group II phospholipase A2 in colonic mucosa of patients with inflammatory bowel disease. Am J Gastroenterol 92:289-292
24. Nevalainen TJ, Märki F, Kortesuo PT, Grütter MG, Di Marco S, Schmitz A (1993) Synovial type (group II) phospholipase in cartilage. J Rheumatol 20:325-330
25. Grönroos JO, Laine VJO, Nevalainen TJ (2002) Bactericidal group IIA phospholipase A2 in serum of patients with bacterial infections. J Infect Dis 185:1767-1772
26. Nevalainen TJ, Eerola LI, Rintala E, Laine VJ, Lambeau G, Gelb MH (2005) Time-resolved fluoroimmunoassays of the complete set of secreted phospholipases A2 in human serum. Biochim Biophys Acta 1733:210-223
27. Laine VJ, Grass DS, Nevalainen TJ (1999) Protection by group II phospholipase A2 against Staphylococcus aureus. J Immunol 162:7402-7408
28. Di Marco S, Märki F, Hofstetter H, Schmitz A, van Oostrum J, Grütter MG (1992) Purification, analysis, and enzymatic activity of recombinant human synovial fluid phospholipase A2 and N-terminal variants. J Biochem 112:350-354
29. Cormier RT, Hong KH, Halberg RB, Hawkins TL, Richardson P, Mulherkar R, Dove WF, Lander ES (1997) Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis. Nat Genet 17:88-91
30. Cormier RT, Bilger A, Lillich AJ, Halberg RB, Hong KH, Gould KA, Borenstein N, Lander ES, Dove WF (2000) The Mom1AKR intestinal tumor resistance region consists of Pla2g2a and a locus distal to D4Mit64. Oncogene 19:3182-3192
31. Belinsky GS, Rajan TV, Saria EA, Giardina C, Rosenberg DW (2007) Expression of secretory phospholipase A2 in colon tumor cells potentiates tumor growth. Mol Carcinog 46:106-116
32. MacPhee M, Chepenik KP, Liddell RA, Nelson KK, Siracusa LD, Buchberg AM (1995) The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMininduced intestinal neoplasia. Cell 81:957-966
33. Dietrich WF, Lander ES, Smith JS, Moser AR, Gould KA, Luongo C, Borenstein N, Dove W (1993) Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 75:631-639
34. Johnson LK, Frank S, Vades P, Pruzanski W, Lusis AJ, Seilhamer JJ (1990) Localization and evolution of two human phospholipase A2 genes and two related genetic elements. Adv Exp Med Biol 275:17-34
35. Leister I, Weith A, Brüderlein S, Cziepluch C, Kangwanpong D, Schlag P, Schwab M (1990) Human colorectal cancer: high frequency of deletions at chromosme 1p35. Cancer Res 50:7232-7235
36. Riggins GJ, Markowitz S, Wilson JK, Vogelstein B, Kinzler KW (1995) Absence of secretory phospholipase A2 gene alterations in human colorectal cancer. Cancer Res 55:5184-5186
37. Praml C, Amler LC, Dihlmann S, Finke LH, Schlag P, Schwab M (1998) Secretory type II phospholipase A2 (PLA2G2A) expression status in colorectal carcinoma derived cell lines and in normal colonic mucosa. Oncogene 17:2009-2012
38. Nevalainen TJ, Haapanen TJ, Rajala P, Ekfors T (1998) Expression of group IIA phospholipase A2 in Paneth cells of an adenoma of the rectum. A case report. APMIS 106:780-784
39. Fijneman RJ, Cormier RT (2008) The roles of sPLA2-IIA (Pla2g2a) in cancer of the small and large intestine. Front Biosci 13:4144-4174
40. Cao Y, Pearman AT, Zimmerman GA, McIntyre TM, Prescott SM (2000) Intracellular unesterified arachidonic acid signals apoptosis. Proc Natl Acad Sci USA 97:11280-11285
41. Ilsley JN, Nakanishi M, Flynn C, Belisnky GS, De Guise S, Adib JN, Dobrowsky RT, Bonventre JV, Rosenberg DW (2005) Cytoplasmic phospholipase A2 deletion enhances colon tumorigenesis. Cancer Res 65:2636-2643
42. Pruzanski W, Stefanski E, Vadas P, Kennedy BP, van den Bosch H (1998) Regulation of the cellular expression of secretory and cytosolic phospholipases A2, and cyclooxygenase-2 by peptide growth factors. Biochim Biophys Acta 1403:47-56
43. Szkaradkiewicz A, Marciniak R, Chudzicka-Strugala I, Wasilewska A, Drews M, Majewski P, Karpinski T, Zwozdziak B (2009) Proinflammatory cytokines and IL-10 in inflammatory bowel disease and colorectal cancer patients. Arch Immunol Ther Exp 57:291-294
44. Zlobec I, Lugli A (2009) Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors. World J Gastroenterol 15:5898-5906
45. Tribler L, Jensen LT, Jorgensen K, Brünner N, Gelb MH, Nielsen HJ, Jensen SS (2007) Increased expression of group IIA and X secretory phospholipase A2 in peritumoural versus central colon carcinoma tissue. Anticancer Res 27:3179-3185